Korean Circ J.  2019 Jan;49(1):109-112. 10.4070/kcj.2018.0365.

New Insight to the Pathogenetic Mechanism of Kawasaki Disease (KD): the Relationship between Clinical Diversity and Genetic Heterogeneity

• Yoo BW

• KMID: 2430754
• DOI: http://doi.org/10.4070/kcj.2018.0365

Abstract

No abstract available.

MeSH Terms

Genetic Heterogeneity*
Mucocutaneous Lymph Node Syndrome*

Reference

1. Chang RK. Epidemiologic characteristics of children hospitalized for Kawasaki disease in California. Pediatr Infect Dis J. 2002; 21:1150–1155.

2. Holman RC, Christensen KY, Belay ED, et al. Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii. Hawaii Med J. 2010; 69:194–197.

3. Fujita Y, Nakamura Y, Sakata K, et al. Kawasaki disease in families. Pediatrics. 1989; 84:666–669.

4. Chi H, Huang FY, Chen MR, et al. ITPKC gene SNP rs28493229 and Kawasaki disease in Taiwanese children. Hum Mol Genet. 2010; 19:1147–1151.

5. Peng Q, Chen CH, Wu Q, et al. Association study of a functional SNP rs28493229 of ITPKC gene and Kawasaki disease in a Chinese population. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011; 28:644–648.

6. Chatzikyriakidou A, Aidinidou L, Giannopoulos A, Papadopoulou-Legbelou K, Kalinderi K, Fidani L. Absence of association of FCGR2A gene polymorphism rs1801274 with Kawasaki disease in Greek patients. Cardiol Young. 2015; 25:681–683.

7. Lin L, Wang SY, Yang SB, Xiao FC. Association between the FCGR2A gene H131R polymorphism and risk of Kawasaki disease: a meta-analysis. Genet Mol Res. 2015; 14:6256–6264.

8. Kwon YC, Kim JJ, Yun SW, et al. Male-specific association of the FCGR2A His167Arg polymorphism with Kawasaki disease. PLoS One. 2017; 12:e0184248.

9. Sim BK, Park HI, Kim JJ, et al. Assessment of the clinical heterogeneity of Kawasaki disease using genetic variants of BLK and FCGR2A. Korean Circ J. 2019; 49:99–108.

10. Joffe A, Kabani A, Jadavji T. Atypical and complicated Kawasaki disease in infants. Do we need criteria? West J Med. 1995; 162:322–327.

11. No SJ, Kim DO, Choi KM, Eun LY. Do predictors of incomplete Kawasaki disease exist for infants? Pediatr Cardiol. 2013; 34:286–290.

12. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Circulation. 2004; 110:2747–2771.

13. Burgner D, Davila S, Breunis WB, et al. A genome-wide association study identifies novel and functionally related susceptibility loci for Kawasaki disease. PLoS Genet. 2009; 5:e1000319.

14. Tsai FJ, Lee YC, Chang JS, et al. Identification of novel susceptibility loci for Kawasaki disease in a Han Chinese population by a genome-wide association study. PLoS One. 2011; 6:e16853.

15. Kim JJ, Hong YM, Sohn S, et al. A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease. Hum Genet. 2011; 129:487–495.

16. Khor CC, Davila S, Breunis WB, et al. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet. 2011; 43:1241–1246.

17. Onouchi Y, Ozaki K, Burns JC, et al. A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet. 2012; 44:517–521.

18. Lee YC, Kuo HC, Chang JS, et al. Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis. Nat Genet. 2012; 44:522–525.

19. Kuo HC, Li SC, Guo MM, et al. Genome-wide association study identifies novel susceptibility genes associated with coronary artery aneurysm formation in Kawasaki disease. PLoS One. 2016; 11:e0154943.

20. Kim JJ, Park YM, Yoon D, et al. Identification of KCNN2 as a susceptibility locus for coronary artery aneurysms in Kawasaki disease using genome-wide association analysis. J Hum Genet. 2013; 58:521–525.